Beruflich Dokumente
Kultur Dokumente
VISIT NOTE
MID CAP
Somany Ceramics
Price: Rs 445
Share Data
Not Rated
13 April 2015
Reuters code
SOCE.BO
Bloomberg code
SOMC IN
Somany Ceramics (SCL) with an installed capacity of ~52 million square meters
278
(including JVs and outsourcing) is the third largest tile manufacturer in India.
0.2
The company has manufacturing plants in Kadi, Gujarat and Kassar, Haryana
39
Performance (%) 1M
3M
12M
Absolute
17
43
156
Relative
17
36
102
and other joint venture plants in Morbi, Gujarat. We recently met the
management of Somany Ceramics to understand the business dynamics and
future prospects for the company.
Valuation ratios
Yr to 31 Mar
Indian tile industry has grown at a CAGR of 14% over CY09-14 and expected to grow at
CAGR of ~17% over the next five years. Key drivers would be pick up in housing
FY 13
FY 14
EPS (Rs)
9.3
7.4
+/- (%)
27.1
(20.0)
PER (x)
7.1
21.8
Dividend/Yield (%)
1.8
0.9
EV/Sales (x)
0.3
0.6
company believes this trend would continue on sustainable basis given rising cost of
EV/EBITDA (x)
4.2
8.9
production for unorganised players (post ban on usage of coal gassifier in Gujarat), higher
activity and government initiatives like Swach Bharat Abhiyan, development of 100
smart cities, development of industrial corridors, housing for all by 2022 programme.
which contribution from organised players is at 40% and rest is from unorganised players.
During the last two years, organised players have managed to grow higher than industry
growth primarily driven by gaining the market share from unorganised players. The
56
FIIs
MFs
Indian tile industry is about Rs 22.5 bn in value terms and 748 msm in volume terms, in
35
SCL is the third largest player with current capacity of 52 msm (Own 21 msm, JV 21
msm and Outsource 9 msm). The company is in the process to increase its capacity to 55
msm through JV and brownfield expansion of Kassar (Haryana) plant.
SCL has market share of ~13% by revenue in the organised segment and have grown at
a CAGR of 23.4% over FY10-14. The company expects the growth momentum to
Relative performance
500
400
300
The company as a business strategy is giving more emphasis on JV model for future
growth given quicker access to capacity at lower cost. This model will help the company
200
to drive robust revenue growth without putting undue pressure on its balance sheet (JV
100
is an asset light model). Though margins could be lower in JV but return on capital
Apr-07
Dec-07
Sep-08
Jun-09
Mar-10
Nov-10
Aug-11
Apr-12
Jan-13
Oct-13
Jul-14
Mar-15
employed is higher.
Major operating cost for the company is power & fuel and stores and spares. The company
has entered into long-term contract for natural gas supply agreements with GAIL, IOCL
and Sabarmati Gas is based on long-term average. Hence, despite correction in spot gas
prices, SCL would not witness sharp correction in its input cost. However, the company
expects gradual moderation in operating cost with higher utilisation, higher sales of valueadded product and benefit of lower gas price.
B&K RESEARCH
APRIL 2015
The companys sanitary ware and bath fittings are mostly sold through the same dealer
network. Recently, Somany has acquired equity stake in M/s Sonec Sanitaryware Pvt. Ltd.
to produce 0.3 mn pieces of sanitary ware per annum and also exploring opportunities
for joint venture in this segment.
During the last two years, the companys profitability adversely impacted (PBT margin
declined from 5.6% in FY10 to 3.5% in FY14) primarily due to high power and fuel costs,
higher marketing spend and increase in overall cost of production due to higher inflation.
Going ahead, the company expect improvement in PBT margin to ~5% over the next two
years.
SCL has passed a resolution to raise Rs 1.5 bn through QIP primarily to fund the
brownfield expansion of Kassar (Haryana) having capex of Rs 750 mn, investment in JV
of ~Rs 150 mn and capex worth of Rs 250 mn for sanitary ware segment.
The companys debt position would remain same of around Rs 1.8 bn during FY16
which has average interest cost of 11.5%.
SCL is currently trading at PER of 20.5x and EV/EBITDA of 11.6x on FY17 consensus
estimates.
Company profile
Somany Ceramics was incorporated in 1968 and is a part of the HL Somany Group. The
company initially started operations in collaboration with UK-based Pilkington Tiles (registered
as Somany Pilkington Ltd.). Later it was renamed as Somany Ceramics in 2007. Somany is
headquartered in Noida, Uttar Pradesh with two own manufacturing units in Kassar, Haryana
(~13 msm) and Kadi, Gujarat (~8 msm) and five JV-based manufacturing facilities in Morbi,
Gujarat (~20 msm). Somany also has outsourcing tie-ups for capacity of ~9 msm. SCLs
product offerings include ceramic wall and floor tiles, glazed and polished vitrified tiles,
internationally-branded tiles, sanitary ware and bathware fittings. It markets its products
though its robust pan-India distribution network consisting of 1,200+ active dealers, 10,000+
sub-dealers, 6,500+ touch points including 223 showrooms, 19 stock points and 31 marketing
offices. The company earns 70% of revenues from the northern and southern markets. It
earns ~2% of revenues from the sanitary ware business.
Key events
Established by
Shri Hiralal
Somany
Collaboration
with Pilkingtons
Tie Holding
First
manufacturing
unit at Kassar
Established
second unit at
Kadi, Gujarat
Indian promoter
bought equity shares
held by Pilkingtons
1968
1971
1972
1981
1996
1998
Changed name
from SPL Ltd. to
Somany
Ceramics Ltd.
Received patent
for VC shield
Acquired 26%
stake in Vintage
Tiles and
Commander
Acquired 26%
stake in Vicon and
Acer and 51%
stake in Aroma
JV for production
2007
2007
2009
2012
2013
2013
SOMANY CERAMICS
Prepared for siddharth.bagadia@enamamc.com - Sent on Monday, April 13, 2015 4:52:40 PM
B&K RESEARCH
APRIL 2015
Capacity break-up
Segment-wise break-up
4%
20%
1%
15%
H&R Johns on
Ceramic Tiles
Kajaria Ceramics
Somany Ceramics
Nitco Tiles
As ian Granito
19%
7%
8%
Others
51%
Others
13%
SOMANY CERAMICS
Prepared for siddharth.bagadia@enamamc.com - Sent on Monday, April 13, 2015 4:52:40 PM
B&K RESEARCH
APRIL 2015
GDP and tiles growth Avg multiplier is 1.5x with a range of
(1.3x-2.6x)
25
43
20
49
%
20
15
10
57
32
0
FY11
FY06
FY14
Own manufacturing
JV
Others
FY07
FY08
FY09
FY10
FY11
FY12
FY13
CY09
CY10
CY11
CY12
CY13
CAGR (%)
China
3,600
4,200
4,800
5,200
5,700
12.2
Brazil
715
754
844
866
871
5.1
India
490
550
617
691
750
11.2
Iran
350
400
475
500
500
9.3
Spain
324
366
392
404
420
6.7
Indonesia
278
287
320
360
390
8.8
Italy
368
387
400
367
363
(0.3)
Turkey
205
245
260
280
340
13.5
Vietnam
295
375
380
290
300
0.4
Mexico
204
210
219
229
228
2.8
25
20
2,000
0
12,629
10
10,539
4,000
8,790
15
7,199
6,000
FY11
FY12
FY13
FY14
Growth (%)
5
0
8.4
10
8.1
6.4
8
6
19.8
9.4
4
814
19.9
12
857
8,000
10.2
741
22.1
10,000
900
800
700
600
500
400
300
200
100
0
678
30
Rs mn
12,000
Rs mn
35
32.8
14,000
553
FY10
FY11
FY12
FY13
FY14
2
0
SOMANY CERAMICS
Prepared for siddharth.bagadia@enamamc.com - Sent on Monday, April 13, 2015 4:52:40 PM
B&K RESEARCH
APRIL 2015
Income Statement
Net sales
7,199
8,790
10,539
12,629
Growth (%)
32.8
22.1
19.9
19.8
Operating expenses
Depreciation
Change in working capital
345
363
478
435
175
183
205
224
(846)
149
(28)
118
(114)
(144)
(148)
(6,521)
(8,049)
(9,682)
(11,815)
Operating profit
678
741
857
814
(80)
EBITDA
678
741
857
814
Others
171
207
200
185
788
710
815
148
(338)
(344)
(684)
(42)
(35)
(461)
148
(380)
(379)
(1,145)
(88)
407
331
(330)
485
Debt raised/(repaid)
163
(120)
(42)
83
(28)
(32)
(48)
(68)
Others
(44)
(191)
(206)
(83)
91
(343)
(296)
417
65
36
87
Growth (%)
22.6
9.3
15.7
(5.1)
Depreciation
(175)
(183)
(205)
(224)
Capital expenditure
12
12
26
31
516
569
678
620
Other income
EBIT
Finance cost
(171)
(207)
(200)
(185)
345
363
478
435
(105)
(111)
(152)
(170)
239
252
326
265
(6)
23
239
252
320
289
239
252
320
289
Growth (%)
20.5
5.2
27.1
(9.8)
Change in investments
Equity raised/(repaid)
Key Ratios
Period end (%)
Balance Sheet
Growth
20.5
CEPS (Rs)
12.0
30.1
0.7
Share capital
6.9
7.3
9.3
7.4
5.2
27.1
(20.0)
12.6
15.2
13.2
36.5
44.4
57.5
0.8
1.2
1.5
11.7
12.7
15.1
23.6
9.4
8.4
8.1
6.4
69
69
69
78
970
1,190
1,461
2,157
1,039
1,259
1,530
2,234
44
1,086
1,092
1,045
1,201
7.2
6.5
6.4
4.9
Long-term borrowings
682
672
616
708
Tax rate
30.5
30.6
31.9
39.1
404
419
429
493
RoCE
Current liabilities
2,692
2,943
3,636
3,991
993
1,008
999
Dividend/share (Rs)
Dividend payout ratio
EBITDA margin
EBIT margin
17.5
17.3
19.6
15.4
1.7
1.3
1.1
0.7
1.6
1.1
0.9
0.4
Net margin
3.3
2.9
3.0
2.3
1.6
1.7
1.8
1.8
4.8
4.4
4.1
3.6
25.7
21.9
22.9
15.3
1,589
1,950
2,628
2,992
5,294
6,211
7,470
Non-current assets
1,849
2,046
2,221
2,770
1,766
1,944
2,092
2,435
10
52
87
177
50
41
159
2,969
3,247
3,990
4,701
158
222
258
717
2,810
3,025
3,732
3,984
4,818
5,294
6,211
7,471
Total debt
1,785
1,666
1,624
1,707
Yield (%)
1.7
2.1
1.8
0.9
Capital employed
3,228
3,344
3,583
4,479
EV/EBITDA
4.5
3.7
4.2
8.9
Return on equity
Valuations
Period end (x)
PER
5.2
7.1
21.8
PCE
3.4
3.0
4.3
12.3
Price/Book
1.4
1.0
1.5
2.8
SOMANY CERAMICS
Prepared for siddharth.bagadia@enamamc.com - Sent on Monday, April 13, 2015 4:52:40 PM
B&K RESEARCH
APRIL 2015
B&K Research
research.equities@bksec.com
+91-22-4031 7000
By Recommendation
160
179
131
140
no. of companies
no. of companies
99
33
120
89
100
80
64
60
40
23
20
NR
UR
0
> $1bn
$200mn - $1bn
<$200mn
Buy
OP
UP
Sell
B&K Securities is the trading name of Batlivala & Karani Securities India Pvt. Ltd.
MID CAP
(Market Cap of USD 200 mn to USD 2 bn)
SMALL CAP
(Market Cap <USD 200 mn)
BUY
OUTPERFORMER
+10% to +20%
+15% to +25%
+20% to +30%
UNDERPERFORMER
+10% to -10%
+15% to -15%
+20% to -20%
SELL
Disclaimer: This report was prepared, approved, published and distributed by Batlivala & Karani Securities India Private Limited ("B&K") located outside
of the United States (a "non-US Group Company"), which accepts responsibility for its contents. It is distributed in the U.S. by Enclave Capital, a U.S.
registered broker dealer, on behalf of B&K, only to major U.S. institutional investors (as defined in Rule 15a-6 under the U.S. Securities Exchange Act of 1934
(the "Exchange Act")) pursuant to the exemption in Rule 15a-6. Neither the report nor any analyst who prepared or approved the report is subject to U.S. legal
requirements or the Financial Industry Regulatory Authority, Inc. ("FINRA") or other regulatory requirements pertaining to research reports or research
analysts. No non-US Group Company is registered as a broker-dealer under the Exchange Act or is a member of the Financial Industry Regulatory Authority,
Inc. or any other U.S. self-regulatory organization. Outside the United States, this report is distributed by B&K or an authorized affiliate of B&K.
The report has been compiled or arrived from sources believed to be reliable and in good faith, but no representation or warranty, express or implied is made
as to their accuracy, completeness or correctness. B&K has not verified the factual accuracy, assumptions, calculations or completeness of the information.
Accordingly, B&K accepts no liability whatsoever for any direct or consequential loss or damage arising from (i) the use of this communication (ii) reliance of
any information contained herein, (iii) any error, omission or inaccuracy in any such Information or (iv) any action resulting there from. B&K provides the
information for the purpose of the intended recipient's analysis and review and recipients are advised to verify the factual accuracy, assumptions, calculations
and completeness of the information.
This report was produced by B&K solely for information purposes and for the use of the recipient. It is not to be reproduced under any circumstances and
is not to be copied or made available to any person other than the recipient. All estimates, expressions of opinion and other subjective judgments contained
herein are made as of the date of this document. Emerging securities markets may be subject to risks significantly higher than more established markets. In
particular, the political and economic environment, company practices and market prices and volumes may be subject to significant variations. The ability to
assess such risks may also be limited due to significantly lower information quantity and quality. By accepting this document, you agree to be bound by all the
foregoing provisions. This document does not constitute an offer of, or an invitation by or on behalf of B&K or its affiliates or any other company to any
person, to buy or sell any security.
The views of any Analyst reflected in this report are given in compliance with the Research Analyst Regulations, 2014. All analysts covering the securities/
companies mentioned in this report have complied will the appropriate set of rules, regulations & procedures in their detailed coverage report(s) of the
respective securities/companies.
Analyst Certification: Each of the analysts identified in this report certifies, with respect to the companies or securities that the individual analyses, that (1)
the views expressed in this report reflect his or her personal views about all of the subject companies and securities and (2) no part of his or her compensation
was, is or will be directly or indirectly dependent on the specific recommendations or views expressed in this report.
Important US Regulatory Disclosures on Subject Companies
1. B&K or its Affiliates have not recently been the beneficial owners of 1% or more of the securities mentioned in this report.
2. B&K or its Affiliates have not managed or co-managed a public offering of the securities mentioned in the report in the past 12 months.
3. B&K or its Affiliates have not received compensation for investment banking services from the issuer of these securities in the past 12 months and do not
expect to receive compensation for investment banking services from the issuer of these securities within the next three months.
4. However, one or more person of B&K or its affiliates may, from time to time, have a long or short position in any of the securities mentioned herein and
may buy or sell those securities or options thereon either on their own account or on behalf of their clients.
5. B&K or its Affiliates may, to the extent permitted by law, act upon or use the above material or the conclusions stated above or the research or analysis on
which they are based before the material is published to recipients and from time to time provide investment banking, investment management or other
services for or solicit to seek to obtain investment banking, or other securities business from, any entity referred to in this report.
6. As of the publication of this report, Enclave Capital does not make a market in the subject securities.
Enclave Capital is the distributor of this document in the United States of America. Any US customer wishing to effect transactions in any securities referred
to herein or options thereon should do so only by contacting a representative of Enclave Capital and any transaction effected by a U.S. customer in the
securities described in this report must be effected through Enclave Capital (19 West 44th Street, suite 1700, New York, NY 10036).
B & K SECURITIES INDIA PRIVATE LTD.
Equity Research Division: City Ice Bldg., 298, Ground/1st Floor, Perin Nariman Street, Behind RBI, Fort, Mumbai - 400 001, India. Tel.: 91-22-4031 7000, Fax: 91-22-2263 5020/30.
Registered Office: Room No. 3/4, 7 Lyons Range, Kolkata - 700 001. Tel.: 91-33-2243 7902.
B&K Research is also available on Bloomberg <BNKI>, Thomson First Call & Investext.